Literature DB >> 10070862

Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity.

B Mytar1, M Siedlar, M Wołoszyn, I Ruggiero, J Pryjma, M Zembala.   

Abstract

The present study examined the ability of human monocytes to produce reactive oxygen intermediates after a contact with tumour cells. Monocytes generated oxygen radicals, as measured by luminol-enhanced chemiluminescence and superoxide anion production, after stimulation with the tumour, but not with untransformed, cells. The use of specific oxygen radical scavengers and inhibitors, superoxide dismutase, catalase, dimethyl sulphoxide and deferoxamine as well as the myeloperoxidase inhibitor 4-aminobenzoic acid hydrazide, indicated that chemiluminescence was dependent on the production of superoxide anion and hydroxyl radical and the presence of myeloperoxidase. The tumour cell-induced chemiluminescent response of monocytes showed different kinetics from that seen after activation of monocytes with phorbol ester. These results indicate that human monocytes can be directly stimulated by tumour cells for reactive oxygen intermediate production. Spontaneous monocyte-mediated cytotoxicity towards cancer cells was inhibited by superoxide dismutase, catalase, deferoxamine and hydrazide, implicating the role of superoxide anion, hydrogen peroxide, hydroxyl radical and hypohalite. We wish to suggest that so-called 'spontaneous' tumoricidal capacity of freshly isolated human monocytes may in fact be an inducible event associated with generation of reactive oxygen intermediates and perhaps other toxic mediators, resulting from a contact of monocytes with tumour cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070862      PMCID: PMC2362686          DOI: 10.1038/sj.bjc.6690118

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

1.  Antioxidant enzyme activities in normal and transformed mouse liver cells.

Authors:  Y Sun; L W Oberley; J H Elwell; E Sierra-Rivera
Journal:  Int J Cancer       Date:  1989-12-15       Impact factor: 7.396

2.  Dissociation of responses measured by natural cytotoxicity and chemiluminescence.

Authors:  M Ernst; A Lange; H D Flad; A Havel; J Ennen; A J Ulmer
Journal:  Eur J Immunol       Date:  1984-07       Impact factor: 5.532

3.  Does a relationship exist between neutrophil myeloperoxidase deficiency and the occurrence of neoplasms?

Authors:  F Lanza; A Fietta; S Spisani; G L Castoldi; S Traniello
Journal:  J Clin Lab Immunol       Date:  1987-04

4.  Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization.

Authors:  S Beissert; M Bergholz; I Waase; G Lepsien; A Schauer; K Pfizenmaier; M Krönke
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

5.  Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism.

Authors:  P Mavier; T S Edgington
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

6.  Distinct tumor cell membrane constituents activate human monocytes for tumor necrosis factor synthesis.

Authors:  R Jänicke; D N Männel
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

7.  Lucigenin-enhanced chemiluminescence in blood is increased in cancer.

Authors:  A Trulson; S Nilsson; P Venge
Journal:  Am J Clin Pathol       Date:  1989-04       Impact factor: 2.493

8.  Evidence for both oxygen and non-oxygen dependent mechanisms of antibody sensitized target cell lysis by human monocytes.

Authors:  D K Klassen; A L Sagone
Journal:  Blood       Date:  1980-12       Impact factor: 22.113

9.  Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader.

Authors:  E Pick; D Mizel
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

10.  Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity.

Authors:  C F Nathan; S C Silverstein; L H Brukner; Z A Cohn
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  9 in total

1.  Aminobenzoic acid hydrazide, a myeloperoxidase inhibitor, alters the adhesive properties of neutrophils isolated from acute myocardial infarction patients.

Authors:  Lili Han; Xiaoli Shen; Leng Pan; Saimei Lin; Xiaoqing Liu; Yulian Deng; Xiaodong Pu
Journal:  Heart Vessels       Date:  2011-08-12       Impact factor: 2.037

2.  Suppression of the reactive oxygen intermediates production of human macrophages by colorectal adenocarcinoma cell lines.

Authors:  A Siegert; C Denkert; A Leclere; S Hauptmann
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

Review 3.  Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts.

Authors:  James D Bryers; Cecilia M Giachelli; Buddy D Ratner
Journal:  Biotechnol Bioeng       Date:  2012-05-24       Impact factor: 4.530

Review 4.  Tumour-associated macrophages and melanoma tumourigenesis: integrating the complexity.

Authors:  Mahmoud R Hussein
Journal:  Int J Exp Pathol       Date:  2006-06       Impact factor: 1.925

5.  Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors.

Authors:  Terry G Coursey; Peter W Chen; Jerry Y Niederkorn
Journal:  Cancer Res       Date:  2011-02-09       Impact factor: 12.701

6.  The study of chemiluminescence in gastric and colonic carcinoma cell lines treated by anti-tumor drugs.

Authors:  Che Chen; Fu-Kun Liu; Xiao-Ping Qi; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

7.  Properties of monocytes generated from haematopoietic CD34(+) stem cells from bone marrow of colon cancer patients.

Authors:  Malgorzata Stec; Jarosław Baran; Rafał Szatanek; Bożenna Mytar; Marzena Lenart; Antoni Czupryna; Antoni Szczepanik; Maciej Siedlar; Marek Zembala
Journal:  Cancer Immunol Immunother       Date:  2012-11-24       Impact factor: 6.968

Review 8.  Biocompatibility Evolves: Phenomenology to Toxicology to Regeneration.

Authors:  Lars Crawford; Meghan Wyatt; James Bryers; Buddy Ratner
Journal:  Adv Healthc Mater       Date:  2021-04-07       Impact factor: 11.092

9.  Macrophages, PPARs, and Cancer.

Authors:  Jo A Van Ginderachter; Kiavash Movahedi; Jan Van den Bossche; Patrick De Baetselier
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.